Covid-19 Impact on Point of Care Testing for Infectious Disease Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Point of Care Testing for Infectious Disease, including the following market information:
Major competitors identified in this market include Abbott, Roche, Siemens, Danaher, Becton, Dickinson, Johnson & Johnson, Instrumentation Laboratory, PTS Diagnostics, Quidel, Sekisui Diagnostics, Nova, EKF Diagnostics, AccuBioTech, Trinity Biotech, etc.
Based on the Region:
- Global Point of Care Testing for Infectious Disease Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Point of Care Testing for Infectious Disease Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Point of Care Testing for Infectious Disease Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Point of Care Testing for Infectious Disease Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Abbott, Roche, Siemens, Danaher, Becton, Dickinson, Johnson & Johnson, Instrumentation Laboratory, PTS Diagnostics, Quidel, Sekisui Diagnostics, Nova, EKF Diagnostics, AccuBioTech, Trinity Biotech, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Immunological Test
- Pathogen Nucleic Acid Test
- Hospital
- Clinics
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Point of Care Testing for Infectious Disease Industry
1.7 COVID-19 Impact: Point of Care Testing for Infectious Disease Market Trends
2 GLOBAL POINT OF CARE TESTING FOR INFECTIOUS DISEASE QUARTERLY MARKET SIZE ANALYSIS
2.1 Point of Care Testing for Infectious Disease Business Impact Assessment - COVID-19
2.1.1 Global Point of Care Testing for Infectious Disease Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Point of Care Testing for Infectious Disease Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Point of Care Testing for Infectious Disease Quarterly Market Size, 2019 VS 2020
3.2 By Players, Point of Care Testing for Infectious Disease Headquarters and Area Served
3.3 Date of Key Players Enter into Point of Care Testing for Infectious Disease Market
3.4 Key Players Point of Care Testing for Infectious Disease Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON POINT OF CARE TESTING FOR INFECTIOUS DISEASE SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Immunological Test
1.4.2 Pathogen Nucleic Acid Test
4.2 By Type, Global Point of Care Testing for Infectious Disease Market Size, 2019-2021
5 IMPACT OF COVID-19 ON POINT OF CARE TESTING FOR INFECTIOUS DISEASE SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospital
5.5.2 Clinics
5.5.3 Others
5.2 By Application, Global Point of Care Testing for Infectious Disease Market Size, 2019-2021
5.2.1 By Application, Global Point of Care Testing for Infectious Disease Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Business Overview
7.1.2 Abbott Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.1.3 Abbott Point of Care Testing for Infectious Disease Product Introduction
7.1.4 Abbott Response to COVID-19 and Related Developments
7.2 Roche
7.2.1 Roche Business Overview
7.2.2 Roche Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.2.3 Roche Point of Care Testing for Infectious Disease Product Introduction
7.2.4 Roche Response to COVID-19 and Related Developments
7.3 Siemens
7.3.1 Siemens Business Overview
7.3.2 Siemens Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.3.3 Siemens Point of Care Testing for Infectious Disease Product Introduction
7.3.4 Siemens Response to COVID-19 and Related Developments
7.4 Danaher
7.4.1 Danaher Business Overview
7.4.2 Danaher Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.4.3 Danaher Point of Care Testing for Infectious Disease Product Introduction
7.4.4 Danaher Response to COVID-19 and Related Developments
7.5 Becton, Dickinson
7.5.1 Becton, Dickinson Business Overview
7.5.2 Becton, Dickinson Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.5.3 Becton, Dickinson Point of Care Testing for Infectious Disease Product Introduction
7.5.4 Becton, Dickinson Response to COVID-19 and Related Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Business Overview
7.6.2 Johnson & Johnson Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.6.3 Johnson & Johnson Point of Care Testing for Infectious Disease Product Introduction
7.6.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.7 Instrumentation Laboratory
7.7.1 Instrumentation Laboratory Business Overview
7.7.2 Instrumentation Laboratory Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.7.3 Instrumentation Laboratory Point of Care Testing for Infectious Disease Product Introduction
7.7.4 Instrumentation Laboratory Response to COVID-19 and Related Developments
7.8 PTS Diagnostics
7.8.1 PTS Diagnostics Business Overview
7.8.2 PTS Diagnostics Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.8.3 PTS Diagnostics Point of Care Testing for Infectious Disease Product Introduction
7.8.4 PTS Diagnostics Response to COVID-19 and Related Developments
7.9 Quidel
7.9.1 Quidel Business Overview
7.9.2 Quidel Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.9.3 Quidel Point of Care Testing for Infectious Disease Product Introduction
7.9.4 Quidel Response to COVID-19 and Related Developments
7.10 Sekisui Diagnostics
7.10.1 Sekisui Diagnostics Business Overview
7.10.2 Sekisui Diagnostics Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.10.3 Sekisui Diagnostics Point of Care Testing for Infectious Disease Product Introduction
7.10.4 Sekisui Diagnostics Response to COVID-19 and Related Developments
7.11 Nova
7.11.1 Nova Business Overview
7.11.2 Nova Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.11.3 Nova Point of Care Testing for Infectious Disease Product Introduction
7.11.4 Nova Response to COVID-19 and Related Developments
7.12 EKF Diagnostics
7.12.1 EKF Diagnostics Business Overview
7.12.2 EKF Diagnostics Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.12.3 EKF Diagnostics Point of Care Testing for Infectious Disease Product Introduction
7.12.4 EKF Diagnostics Response to COVID-19 and Related Developments
7.13 AccuBioTech
7.13.1 AccuBioTech Business Overview
7.13.2 AccuBioTech Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.13.3 AccuBioTech Point of Care Testing for Infectious Disease Product Introduction
7.13.4 AccuBioTech Response to COVID-19 and Related Developments
7.14 Trinity Biotech
7.14.1 Trinity Biotech Business Overview
7.14.2 Trinity Biotech Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.14.3 Trinity Biotech Point of Care Testing for Infectious Disease Product Introduction
7.14.4 Trinity Biotech Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Point of Care Testing for Infectious Disease Industry
1.7 COVID-19 Impact: Point of Care Testing for Infectious Disease Market Trends
2 GLOBAL POINT OF CARE TESTING FOR INFECTIOUS DISEASE QUARTERLY MARKET SIZE ANALYSIS
2.1 Point of Care Testing for Infectious Disease Business Impact Assessment - COVID-19
2.1.1 Global Point of Care Testing for Infectious Disease Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Point of Care Testing for Infectious Disease Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Point of Care Testing for Infectious Disease Quarterly Market Size, 2019 VS 2020
3.2 By Players, Point of Care Testing for Infectious Disease Headquarters and Area Served
3.3 Date of Key Players Enter into Point of Care Testing for Infectious Disease Market
3.4 Key Players Point of Care Testing for Infectious Disease Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON POINT OF CARE TESTING FOR INFECTIOUS DISEASE SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Immunological Test
1.4.2 Pathogen Nucleic Acid Test
4.2 By Type, Global Point of Care Testing for Infectious Disease Market Size, 2019-2021
5 IMPACT OF COVID-19 ON POINT OF CARE TESTING FOR INFECTIOUS DISEASE SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospital
5.5.2 Clinics
5.5.3 Others
5.2 By Application, Global Point of Care Testing for Infectious Disease Market Size, 2019-2021
5.2.1 By Application, Global Point of Care Testing for Infectious Disease Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Business Overview
7.1.2 Abbott Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.1.3 Abbott Point of Care Testing for Infectious Disease Product Introduction
7.1.4 Abbott Response to COVID-19 and Related Developments
7.2 Roche
7.2.1 Roche Business Overview
7.2.2 Roche Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.2.3 Roche Point of Care Testing for Infectious Disease Product Introduction
7.2.4 Roche Response to COVID-19 and Related Developments
7.3 Siemens
7.3.1 Siemens Business Overview
7.3.2 Siemens Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.3.3 Siemens Point of Care Testing for Infectious Disease Product Introduction
7.3.4 Siemens Response to COVID-19 and Related Developments
7.4 Danaher
7.4.1 Danaher Business Overview
7.4.2 Danaher Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.4.3 Danaher Point of Care Testing for Infectious Disease Product Introduction
7.4.4 Danaher Response to COVID-19 and Related Developments
7.5 Becton, Dickinson
7.5.1 Becton, Dickinson Business Overview
7.5.2 Becton, Dickinson Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.5.3 Becton, Dickinson Point of Care Testing for Infectious Disease Product Introduction
7.5.4 Becton, Dickinson Response to COVID-19 and Related Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Business Overview
7.6.2 Johnson & Johnson Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.6.3 Johnson & Johnson Point of Care Testing for Infectious Disease Product Introduction
7.6.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.7 Instrumentation Laboratory
7.7.1 Instrumentation Laboratory Business Overview
7.7.2 Instrumentation Laboratory Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.7.3 Instrumentation Laboratory Point of Care Testing for Infectious Disease Product Introduction
7.7.4 Instrumentation Laboratory Response to COVID-19 and Related Developments
7.8 PTS Diagnostics
7.8.1 PTS Diagnostics Business Overview
7.8.2 PTS Diagnostics Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.8.3 PTS Diagnostics Point of Care Testing for Infectious Disease Product Introduction
7.8.4 PTS Diagnostics Response to COVID-19 and Related Developments
7.9 Quidel
7.9.1 Quidel Business Overview
7.9.2 Quidel Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.9.3 Quidel Point of Care Testing for Infectious Disease Product Introduction
7.9.4 Quidel Response to COVID-19 and Related Developments
7.10 Sekisui Diagnostics
7.10.1 Sekisui Diagnostics Business Overview
7.10.2 Sekisui Diagnostics Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.10.3 Sekisui Diagnostics Point of Care Testing for Infectious Disease Product Introduction
7.10.4 Sekisui Diagnostics Response to COVID-19 and Related Developments
7.11 Nova
7.11.1 Nova Business Overview
7.11.2 Nova Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.11.3 Nova Point of Care Testing for Infectious Disease Product Introduction
7.11.4 Nova Response to COVID-19 and Related Developments
7.12 EKF Diagnostics
7.12.1 EKF Diagnostics Business Overview
7.12.2 EKF Diagnostics Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.12.3 EKF Diagnostics Point of Care Testing for Infectious Disease Product Introduction
7.12.4 EKF Diagnostics Response to COVID-19 and Related Developments
7.13 AccuBioTech
7.13.1 AccuBioTech Business Overview
7.13.2 AccuBioTech Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.13.3 AccuBioTech Point of Care Testing for Infectious Disease Product Introduction
7.13.4 AccuBioTech Response to COVID-19 and Related Developments
7.14 Trinity Biotech
7.14.1 Trinity Biotech Business Overview
7.14.2 Trinity Biotech Point of Care Testing for Infectious Disease Quarterly Revenue, 2020
7.14.3 Trinity Biotech Point of Care Testing for Infectious Disease Product Introduction
7.14.4 Trinity Biotech Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Point of Care Testing for Infectious Disease Assessment
Table 9. COVID-19 Impact: Point of Care Testing for Infectious Disease Market Trends
Table 10. COVID-19 Impact Global Point of Care Testing for Infectious Disease Market Size
Table 11. Global Point of Care Testing for Infectious Disease Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Point of Care Testing for Infectious Disease Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Point of Care Testing for Infectious Disease Market Growth Drivers
Table 14. Global Point of Care Testing for Infectious Disease Market Restraints
Table 15. Global Point of Care Testing for Infectious Disease Market Opportunities
Table 16. Global Point of Care Testing for Infectious Disease Market Challenges
Table 17. By Players, Point of Care Testing for Infectious Disease Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Point of Care Testing for Infectious Disease Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Point of Care Testing for Infectious Disease Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Point of Care Testing for Infectious Disease Market
Table 21. Key Players Point of Care Testing for Infectious Disease Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Point of Care Testing for Infectious Disease Market Size 2019-2021, (US$ Million)
Table 24. Global Point of Care Testing for Infectious Disease Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Point of Care Testing for Infectious Disease Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 57. Abbott Business Overview
Table 58. Abbott Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Point of Care Testing for Infectious Disease Product
Table 60. Abbott Response to COVID-19 and Related Developments
Table 61. Roche Business Overview
Table 62. Roche Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Roche Point of Care Testing for Infectious Disease Product
Table 64. Roche Response to COVID-19 and Related Developments
Table 65. Siemens Business Overview
Table 66. Siemens Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Siemens Point of Care Testing for Infectious Disease Product
Table 68. Siemens Response to COVID-19 and Related Developments
Table 69. Danaher Business Overview
Table 70. Danaher Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Danaher Point of Care Testing for Infectious Disease Product
Table 72. Danaher Response to COVID-19 and Related Developments
Table 73. Becton, Dickinson Business Overview
Table 74. Becton, Dickinson Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Becton, Dickinson Point of Care Testing for Infectious Disease Product
Table 76. Becton, Dickinson Response to COVID-19 and Related Developments
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Johnson & Johnson Point of Care Testing for Infectious Disease Product
Table 80. Johnson & Johnson Response to COVID-19 and Related Developments
Table 81. Instrumentation Laboratory Business Overview
Table 82. Instrumentation Laboratory Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Instrumentation Laboratory Point of Care Testing for Infectious Disease Product
Table 84. Instrumentation Laboratory Response to COVID-19 and Related Developments
Table 85. PTS Diagnostics Business Overview
Table 86. PTS Diagnostics Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. PTS Diagnostics Point of Care Testing for Infectious Disease Product
Table 88. PTS Diagnostics Response to COVID-19 and Related Developments
Table 89. Quidel Business Overview
Table 90. Quidel Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Quidel Point of Care Testing for Infectious Disease Product
Table 92. Quidel Response to COVID-19 and Related Developments
Table 93. Sekisui Diagnostics Business Overview
Table 94. Sekisui Diagnostics Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Sekisui Diagnostics Point of Care Testing for Infectious Disease Product
Table 96. Sekisui Diagnostics Response to COVID-19 and Related Developments
Table 97. Nova Business Overview
Table 98. Nova Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Nova Point of Care Testing for Infectious Disease Product
Table 100. Nova Response to COVID-19 and Related Developments
Table 101. EKF Diagnostics Business Overview
Table 102. EKF Diagnostics Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. EKF Diagnostics Point of Care Testing for Infectious Disease Product
Table 104. EKF Diagnostics Response to COVID-19 and Related Developments
Table 105. AccuBioTech Business Overview
Table 106. AccuBioTech Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. AccuBioTech Point of Care Testing for Infectious Disease Product
Table 108. AccuBioTech Response to COVID-19 and Related Developments
Table 109. Trinity Biotech Business Overview
Table 110. Trinity Biotech Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Trinity Biotech Point of Care Testing for Infectious Disease Product
Table 112. Trinity Biotech Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Point of Care Testing for Infectious Disease Assessment
Table 9. COVID-19 Impact: Point of Care Testing for Infectious Disease Market Trends
Table 10. COVID-19 Impact Global Point of Care Testing for Infectious Disease Market Size
Table 11. Global Point of Care Testing for Infectious Disease Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Point of Care Testing for Infectious Disease Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Point of Care Testing for Infectious Disease Market Growth Drivers
Table 14. Global Point of Care Testing for Infectious Disease Market Restraints
Table 15. Global Point of Care Testing for Infectious Disease Market Opportunities
Table 16. Global Point of Care Testing for Infectious Disease Market Challenges
Table 17. By Players, Point of Care Testing for Infectious Disease Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Point of Care Testing for Infectious Disease Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Point of Care Testing for Infectious Disease Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Point of Care Testing for Infectious Disease Market
Table 21. Key Players Point of Care Testing for Infectious Disease Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Point of Care Testing for Infectious Disease Market Size 2019-2021, (US$ Million)
Table 24. Global Point of Care Testing for Infectious Disease Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Point of Care Testing for Infectious Disease Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Point of Care Testing for Infectious Disease Market Size, 2019-2021 (US$ Million)
Table 57. Abbott Business Overview
Table 58. Abbott Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Point of Care Testing for Infectious Disease Product
Table 60. Abbott Response to COVID-19 and Related Developments
Table 61. Roche Business Overview
Table 62. Roche Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Roche Point of Care Testing for Infectious Disease Product
Table 64. Roche Response to COVID-19 and Related Developments
Table 65. Siemens Business Overview
Table 66. Siemens Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Siemens Point of Care Testing for Infectious Disease Product
Table 68. Siemens Response to COVID-19 and Related Developments
Table 69. Danaher Business Overview
Table 70. Danaher Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Danaher Point of Care Testing for Infectious Disease Product
Table 72. Danaher Response to COVID-19 and Related Developments
Table 73. Becton, Dickinson Business Overview
Table 74. Becton, Dickinson Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Becton, Dickinson Point of Care Testing for Infectious Disease Product
Table 76. Becton, Dickinson Response to COVID-19 and Related Developments
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Johnson & Johnson Point of Care Testing for Infectious Disease Product
Table 80. Johnson & Johnson Response to COVID-19 and Related Developments
Table 81. Instrumentation Laboratory Business Overview
Table 82. Instrumentation Laboratory Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Instrumentation Laboratory Point of Care Testing for Infectious Disease Product
Table 84. Instrumentation Laboratory Response to COVID-19 and Related Developments
Table 85. PTS Diagnostics Business Overview
Table 86. PTS Diagnostics Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. PTS Diagnostics Point of Care Testing for Infectious Disease Product
Table 88. PTS Diagnostics Response to COVID-19 and Related Developments
Table 89. Quidel Business Overview
Table 90. Quidel Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Quidel Point of Care Testing for Infectious Disease Product
Table 92. Quidel Response to COVID-19 and Related Developments
Table 93. Sekisui Diagnostics Business Overview
Table 94. Sekisui Diagnostics Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Sekisui Diagnostics Point of Care Testing for Infectious Disease Product
Table 96. Sekisui Diagnostics Response to COVID-19 and Related Developments
Table 97. Nova Business Overview
Table 98. Nova Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Nova Point of Care Testing for Infectious Disease Product
Table 100. Nova Response to COVID-19 and Related Developments
Table 101. EKF Diagnostics Business Overview
Table 102. EKF Diagnostics Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. EKF Diagnostics Point of Care Testing for Infectious Disease Product
Table 104. EKF Diagnostics Response to COVID-19 and Related Developments
Table 105. AccuBioTech Business Overview
Table 106. AccuBioTech Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. AccuBioTech Point of Care Testing for Infectious Disease Product
Table 108. AccuBioTech Response to COVID-19 and Related Developments
Table 109. Trinity Biotech Business Overview
Table 110. Trinity Biotech Point of Care Testing for Infectious Disease Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Trinity Biotech Point of Care Testing for Infectious Disease Product
Table 112. Trinity Biotech Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Point of Care Testing for Infectious Disease Product Picture
Figure 2. Point of Care Testing for Infectious Disease Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Point of Care Testing for Infectious Disease Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Point of Care Testing for Infectious Disease Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Point of Care Testing for Infectious Disease Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Point of Care Testing for Infectious Disease Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Point of Care Testing for Infectious Disease Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Point of Care Testing for Infectious Disease Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Point of Care Testing for Infectious Disease Market Size Market Share, 2019-2021
Figure 1. Point of Care Testing for Infectious Disease Product Picture
Figure 2. Point of Care Testing for Infectious Disease Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Point of Care Testing for Infectious Disease Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Point of Care Testing for Infectious Disease Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Point of Care Testing for Infectious Disease Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Point of Care Testing for Infectious Disease Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Point of Care Testing for Infectious Disease Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Point of Care Testing for Infectious Disease Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Point of Care Testing for Infectious Disease Market Size Market Share, 2019-2021
